Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

about

Deletion of Chromosomal Region 8p21 Confers Resistance to Bortezomib and Is Associated with Upregulated Decoy TRAIL Receptor Expression in Patients with Multiple Myeloma.

Item

http://www.wikidata.org/entity/Q35778422

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@ast

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@en

type

Item

label

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@ast

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@en

prefLabel

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@ast

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@en

P1476

Deletion of Chromosomal Region ...... atients with Multiple Myeloma.

@en

P2093

Ann Wallblom

http://www.w3.org/2001/XMLSchema#string

Birgitta Stellan

http://www.w3.org/2001/XMLSchema#string

Gösta Gahrton

http://www.w3.org/2001/XMLSchema#string

Johan Lund

http://www.w3.org/2001/XMLSchema#string

Katarina Uttervall

http://www.w3.org/2001/XMLSchema#string

Tolga Sutlu

http://www.w3.org/2001/XMLSchema#string

P2860

Noxa/Bcl-2 protein interactions contribute to bortezomib resistance in human lymphoid cells

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

Differential localization and regulation of death and decoy receptors for TNF-related apoptosis-inducing ligand (TRAIL) in human melanoma cells

Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF-kappaB and JNK activation and apoptosis through distinct pathways

Proteasome inhibition suppresses essential immune functions of human CD4+ T cells.

Combining information regarding chromosomal aberrations t(4;14) and del(17p13) with the International Staging System classification allows stratification of myeloma patients undergoing autologous stem cell transplantation.

Critical role for tumor necrosis factor-related apoptosis-inducing ligand in immune surveillance against tumor development.

Pyk2 promotes tumor progression in multiple myeloma

The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

P304

e0138248

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0138248

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Evren Alici

Adil Doganay Duru

Hareth Nahi

P577

2015-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282039585

http://www.w3.org/2001/XMLSchema#string

P698

26378933

http://www.w3.org/2001/XMLSchema#string

P932

4574561

http://www.w3.org/2001/XMLSchema#string